Nasdaq to suspend Aditxt trading pending final SPAC merger vote
Nasdaq upheld the denial of Aditxt's listing request, suspending trading June 25. The move threatens the company's market access ahead of a shareholder vote to finalize a SPAC merger with Ignite Proteomics.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day